Kiora Pharmaceuticals Inc (KPRX) — Cash Flow Quality Index
Kiora Pharmaceuticals Inc (KPRX) has a Cash Flow Quality Index of -47.49x as of September 2025. Operating cash flow of $-1.27 Million is below net income of $26.81K, suggesting accrual-heavy earnings not yet converted to cash. Explore KPRX operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Kiora Pharmaceuticals Inc Cash Flow Quality Index (2024–2024)
Historical Cash Flow Quality Index for Kiora Pharmaceuticals Inc across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see Kiora Pharmaceuticals Inc cash flow conversion.
Annual Cash Flow Quality Index for Kiora Pharmaceuticals Inc (2024–2024)
Year-by-year earnings quality comparison for Kiora Pharmaceuticals Inc.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 2.38x | $8.56 Million | $3.59 Million | — |